Whitehawk Therapeutics (WHWK) Debt Ratio (2020 - 2021)
Whitehawk Therapeutics' (WHWK) quarterly Debt Ratio came in at 0.04 in Q4 2021, down 94.99% year-on-year from 0.76 in Q4 2020, and up 11.24% on a QoQ basis from 0.03 in Q3 2021.
Whitehawk Therapeutics (WHWK) Debt Ratio (2020 - 2021) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 2 years of Debt Ratio data on file, last reported at 0.04 in Q4 2021.
- On a quarterly basis, Debt Ratio fell 94.99% year-over-year to 0.04 in Q4 2021; TTM through Dec 2021 was 0.04, a 94.99% decrease from a year earlier, with the FY2021 full-year figure at 0.04, down 94.99% from the prior year.
- Debt Ratio for Q4 2021 stood at 0.04, up from 0.03 in the prior quarter.
- Over the last five years, Debt Ratio for WHWK reached as high as 0.76 in Q4 2020 and fell as low as 0.03 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.03 |
| Dec 31, 2020 | 0.76 |